Biological Psychiatry
Ketamine shows significant therapeutic benefit in people with treatment-resistant depression
Patients with treatment-resistant major depression saw dramatic improvement in their illness after treatment with ketamine, an anesthetic, according to the largest ketamine clinical trial to-date led by researchers from the ...
Psychology & Psychiatry
May 19, 2013 |
4.8 / 5 (6) |
1
|
Expert explores how sunlight may affect ADHD patients
Researchers are interested in exploring how sunlight, sleep and screens (like those on computers and TVs) may affect those with attention-deficit/hyperactivity disorder (ADHD), says Dr. L. Eugene Arnold, a child psychiatrist ...
Attention deficit disorders
May 17, 2013 |
5 / 5 (3) |
0
Genetic risk for schizophrenia is connected to reduced IQ
The relationship between the heritable risk for schizophrenia and low intelligence (IQ) has not been clear. Schizophrenia is commonly associated with cognitive impairments that may cause functional disability. There are clues ...
Psychology & Psychiatry
May 16, 2013 |
4.5 / 5 (2) |
0
|
Autism risk spotted at birth in abnormal placentas
Researchers at the Yale School of Medicine have figured out how to measure an infant's risk of developing autism by looking for abnormalities in his/her placenta at birth, allowing for earlier diagnosis and ...
Autism spectrum disorders
Apr 25, 2013 |
3.8 / 5 (4) |
0
|
Increased brain activity predicts future onset of substance use
Do people get caught in the cycle of overeating and drug addiction because their brain reward centers are over-active causing them to experience greater cravings for food or drugs? In a unique prospective study Oregon Research ...
Psychology & Psychiatry
Apr 18, 2013 |
4 / 5 (1) |
0
Stimulating the brain blunts cigarette craving
Cigarette smoking is the leading cause of preventable deaths globally. Unfortunately smoking cessation is difficult, with more than 90% of attempts to quit resulting in relapse.
Psychology & Psychiatry
Apr 16, 2013 |
5 / 5 (4) |
0
A new treatment option for alcohol dependence: Reduced consumption rather than abstinence
A potential new treatment for alcoholism called nalmefene is effective and safe for reducing alcohol consumption in alcohol dependent individuals, says a new study published this week in Biological Psychiatry.
Psychology & Psychiatry
Apr 11, 2013 |
5 / 5 (1) |
1
Success in patients with major depression: For the first time, physicians stimulated patients' medial forebrain bundles
Researchers from the Bonn University Hospital implanted pacemaker electrodes into the medial forebrain bundle in the brains of patients suffering from major depression with amazing results: In six out of ...
Psychology & Psychiatry
Apr 09, 2013 |
4.9 / 5 (7) |
5
Common gene variants explain 42% of antidepressant response
Antidepressants are commonly prescribed for the treatment of depression, but many individuals do not experience symptom relief from treatment. The National Institute of Mental Health's STAR*D study, the largest and longest ...
Psychology & Psychiatry
Mar 28, 2013 |
4 / 5 (1) |
0
Human emotion: We report our feelings in 3-D
Like it or not and despite the surrounding debate of its merits, 3-D is the technology du jour for movie-making in Hollywood. It now turns out that even our brains use 3 dimensions to communicate emotions.
Psychology & Psychiatry
Mar 26, 2013 |
5 / 5 (1) |
1
|
The mysterious GRIN3A and the cause of schizophrenia
Since the 1960s, psychiatrists have been hunting for substances made by the body that might accumulate in abnormally high levels to produce the symptoms associated with schizophrenia. In particular, there was a search for ...
Psychology & Psychiatry
Mar 14, 2013 |
4 / 5 (1) |
0
Neuron loss in schizophrenia and depression could be prevented
Gamma-aminobutyric acid (GABA) deficits have been implicated in schizophrenia and depression. In schizophrenia, deficits have been particularly well-described for a subtype of GABA neuron, the parvalbumin fast-spiking interneurons. ...
Neuroscience
Mar 13, 2013 |
5 / 5 (1) |
0
Tickling the brain with magnetic stimulation improves memory in schizophrenia
Cognitive impairments are disabling for individuals with schizophrenia, and no satisfactory treatments currently exist. These impairments affect a wide range of cognition, including memory, attention, verbal and motor skills, ...
Psychology & Psychiatry
Mar 12, 2013 |
5 / 5 (3) |
0
|
Stroke risk in elderly treated with antipsychotics is newly linked to specific drug actions
Antipsychotic administration in the elderly is associated with an increased risk for cerebrovascular accident, more commonly known as stroke; a new study published in Biological Psychiatry provides additional insight into t ...
Psychology & Psychiatry
Mar 11, 2013 |
not rated yet |
0
Worming our way to new treatments for Alzheimer's disease
According to a 2012 World Health Organization report, over 35 million people worldwide currently have dementia, a number that is expected to double by 2030 (66 million) and triple by 2050 (115 million). Alzheimer's disease, ...
Alzheimer's disease & dementia
Mar 07, 2013 |
5 / 5 (2) |
0
|
